| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
5.8 |
% |
10.6019/CHEMBL4513141 |
| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
12589.3 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
22387.2 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
28183.8 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
29620.3 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
41839.8 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
50118.7 |
nM |
None |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
9.31 |
% |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Canis lupus familiaris |
Canis familiaris |
Inhibition |
nan |
% |
10.1016/j.bmc.2012.04.014 |
| Canis lupus familiaris |
Canis familiaris |
Inhibition |
nan |
% |
10.1016/j.bmc.2017.04.014 |
| Canis lupus familiaris |
Canis familiaris |
Inhibition |
nan |
% |
10.1021/jm300318t |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-23.82 |
% |
10.6019/CHEMBL4513141 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
346.6 |
nM |
10.1016/j.bmcl.2011.10.028 |
| Escherichia coli |
Escherichia coli |
Inhibition |
-0.87 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Inhibition |
5.0 |
% |
10.1021/jm030191r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
89125.1 |
nM |
None |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
73.1 |
nM |
10.1016/j.bmcl.2011.10.028 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
9976.3 |
nM |
None |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
19905.4 |
nM |
None |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
25059.4 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
16820.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
7770.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
AGS |
IC50 |
149000.0 |
nM |
10.1016/j.bmcl.2015.04.095 |
| Homo sapiens |
AGS |
IC50 |
162000.0 |
nM |
10.1021/np900822x |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-galactosidase A |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Alpha-synuclein |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Amyloid-beta A4 protein |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
20596.2 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
29081.0 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
14400.0 |
nM |
10.1016/j.ejmech.2022.114346 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
135000.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bromodomain adjacent to zinc finger domain protein 2B |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Bromodomain adjacent to zinc finger domain protein 2B |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
BXPC-3 |
Activity |
nan |
None |
10.1021/jm501543u |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
34.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
21980.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholesterol 24-hydroxylase |
Activity |
86.0 |
% |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
26679.5 |
nM |
None |
| Homo sapiens |
Chymotrypsin |
Inhibition |
5.66 |
% |
10.6019/CHEMBL4495564 |
| Homo sapiens |
Chymotrypsin |
Inhibition |
6.43 |
% |
10.6019/CHEMBL4495564 |
| Homo sapiens |
Chymotrypsin C |
Inhibition |
5.0 |
% |
10.1021/jm030191r |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
15848.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
6460.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
100.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
336.7 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
13400.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C19 |
Inhibition |
86.0 |
% |
10.1021/jm501203v |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
100.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C8 |
IC50 |
5750.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
19200.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
2900.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
5314.8 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2J2 |
Activity |
0.7 |
% |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2J2 |
Activity |
71.1 |
% |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
15848.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
8300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
2106.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endo-beta-N-acetylglucosaminidase |
IC50 |
24380.0 |
nM |
10.1016/j.bmcl.2017.05.010 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
501.2 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Fatty acid synthase |
IC50 |
46700.0 |
nM |
10.1021/jm501543u |
| Homo sapiens |
Fatty acid synthase |
IC50 |
93000.0 |
nM |
10.1021/jm501543u |
| Homo sapiens |
Fatty acid synthase |
IC50 |
124000.0 |
nM |
10.1021/jm501543u |
| Homo sapiens |
Fatty acid synthase |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.2c00642 |
| Homo sapiens |
Fatty acid synthase |
Inhibition |
nan |
% |
10.1021/jm501543u |
| Homo sapiens |
Fatty acid synthase |
Ki |
1700.0 |
nM |
10.1021/acs.jmedchem.2c00642 |
| Homo sapiens |
Fatty acid synthase |
Ki |
5300.0 |
nM |
10.1021/jm501543u |
| Homo sapiens |
GABA-B receptor 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
9670.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HEK293 |
CC50 |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Homo sapiens |
HEK293 |
Potency |
1157.7 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
HEK-293T |
Activity |
nan |
None |
10.1016/j.bmcl.2012.10.010 |
| Homo sapiens |
HepG2 |
IC50 |
221000.0 |
nM |
10.1021/np900822x |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
8523.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-46.91 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
6.18 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase 2A/WDR5 |
IC50 |
5900.0 |
nM |
10.1016/j.ejmech.2019.112027 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
22.4 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
281.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
502.4 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
6701.6 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Activity |
0.85 |
% |
10.1016/j.ejmech.2009.11.034 |
| Homo sapiens |
Homo sapiens |
CL |
4.4 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
4.4 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.04 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.044 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
80.0 |
% |
10.1016/j.bmc.2007.08.060 |
| Homo sapiens |
Homo sapiens |
Fa |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.85 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
1.05 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.81 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
0.28 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
0.35 |
L.kg-1 |
10.1016/j.ejmech.2009.06.004 |
| Homo sapiens |
HUVEC |
GI50 |
100000.0 |
nM |
10.1016/j.ejmech.2019.112027 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Insulin-degrading enzyme |
Inhibition |
38.0 |
% |
10.1016/j.ejmech.2019.06.057 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
K562 |
GI50 |
100000.0 |
nM |
10.1016/j.ejmech.2019.112027 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
4882.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
L02 |
GI50 |
100000.0 |
nM |
10.1016/j.ejmech.2019.112027 |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Lysine-specific demethylase 4A |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Lysosomal alpha-glucosidase |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Malate dehydrogenase cytoplasmic |
Inhibition |
5.0 |
% |
10.1021/jm030191r |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MDA-MB-231 |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00642 |
| Homo sapiens |
MDA-MB-436 |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00642 |
| Homo sapiens |
MDA-MB-468 |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00642 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
microRNA 21 |
Potency |
6561.4 |
nM |
None |
| Homo sapiens |
microRNA 21 |
Potency |
10399.2 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Ki |
2.5 |
nM |
10.1021/ml300216t |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
MOLM-13 |
GI50 |
30100.0 |
nM |
10.1016/j.ejmech.2019.112027 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
23778.1 |
nM |
None |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
MRC5 |
IC50 |
306000.0 |
nM |
10.1021/np900822x |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
4000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
4200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
MV4-11 |
GI50 |
21100.0 |
nM |
10.1016/j.ejmech.2019.112027 |
| Homo sapiens |
NAD(+) hydrolase SARM1 |
Inhibition |
nan |
% |
None |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
17152.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
24469.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 |
IC50 |
51000.0 |
nM |
None |
| Homo sapiens |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 |
Inhibition |
nan |
% |
None |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
2310.9 |
nM |
None |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
PANC-1 |
Activity |
nan |
None |
10.1021/jm501543u |
| Homo sapiens |
PANC-1 |
Inhibition |
nan |
% |
10.1021/jm501543u |
| Homo sapiens |
Peripheral myelin protein 22 |
Potency |
95283.4 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1007/s00210-001-0489-7 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
62800.0 |
nM |
10.1007/s00210-001-0489-7 |
| Homo sapiens |
Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Phosphoethanolamine/phosphocholine phosphatase |
IC50 |
434.0 |
nM |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Potassium-transporting ATPase |
IC50 |
398.11 |
nM |
10.1021/jm00084a010 |
| Homo sapiens |
Prelamin-A/C |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
2310.9 |
nM |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
16833.6 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase PLK1 |
Potency |
26679.5 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
2300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Sodium/potassium-transporting ATPase |
IC50 |
39810.72 |
nM |
10.1021/jm00084a010 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
31.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
95.47 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
23.3 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
100.47 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
-75.7 |
% |
10.1021/jm300212s |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
3460.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9441.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
10322.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
20596.2 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
21136.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
44668.4 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
7.47 |
% |
10.6019/CHEMBL4513141 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (Betacoronavirus England 1) (Humancoronavirus EMC) |
Replicase polyprotein 1ab |
IC50 |
10000.0 |
nM |
10.6019/CHEMBL4495564 |
| Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (Betacoronavirus England 1) (Humancoronavirus EMC) |
Replicase polyprotein 1ab |
Inhibition |
47.0 |
% |
10.6019/CHEMBL4495564 |
| Mus musculus |
Indoleamine 2,3-dioxygenase 1 |
IC50 |
94000.0 |
nM |
10.1016/j.bmcl.2012.10.010 |
| Mus musculus |
Indoleamine 2,3-dioxygenase 2 |
IC50 |
8200.0 |
nM |
10.1016/j.bmcl.2012.10.010 |
| Mus musculus |
Mus musculus |
Activity |
74.0 |
% |
10.1016/j.bmcl.2016.10.056 |
| Mus musculus |
Mus musculus |
Activity |
80.0 |
% |
10.1021/np900822x |
| Mus musculus |
Mus musculus |
Inhibition |
57.0 |
% |
10.1016/j.bmcl.2015.04.095 |
| Mus musculus |
Mus musculus |
Inhibition |
57.0 |
% |
10.1016/j.bmcl.2016.05.081 |
| Mus musculus |
Mus musculus |
Inhibition |
63.0 |
% |
10.1007/s00044-011-9654-9 |
| Mus musculus |
Mus musculus |
Inhibition |
64.0 |
% |
10.1016/j.ejmech.2014.10.023 |
| Mus musculus |
Mus musculus |
Inhibition |
65.0 |
% |
10.1016/j.bmcl.2015.04.095 |
| Mus musculus |
Mus musculus |
UI |
16.1 |
mm |
10.1016/j.bmcl.2016.05.081 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
11220.2 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
15848.9 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
35481.3 |
nM |
None |
| Mus musculus |
Tryptophan 2,3-dioxygenase |
Inhibition |
20.0 |
% |
10.1016/j.bmcl.2012.10.010 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
2200.0 |
nM |
10.1016/j.ejmech.2018.03.020 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
13459.1 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
10000.0 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
11000.0 |
nM |
10.1016/j.bmc.2010.01.068 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12589.25 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1041.8 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
3696.4 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
5358.2 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
11.72 |
% |
10.6019/CHEMBL4513141 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
56.2 |
nM |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
14381.8 |
nM |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.021 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Plasma |
logFu |
0.03 |
None |
10.1016/j.ejmech.2009.06.004 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
39300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
272.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
288.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
333.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
387.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
36.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
39.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
48.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
52.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
76.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
81.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
83.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
84.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
136.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
163.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
166.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
103.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
103.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
104.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
106.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
513.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
553.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
813.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
820.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
144.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
222.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
222.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
302.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
22330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
25330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
28000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
28330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
3.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
38.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1386.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1470.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1590.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1620.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.9 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
37.37 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
129000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
135700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
136700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
nan |
% |
10.1016/j.bmc.2017.04.014 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
nan |
% |
10.1021/jm300318t |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
71.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
91.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
157.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
455.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
12.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
13.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
11302.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12566.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13053.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
15467.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
87.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
93.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
94.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.33 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.47 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.73 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
363000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
371700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
375300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
378000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.7 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.53 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
64.3 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
66.5 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
38.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
222.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
465.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
599.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
3.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
5.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
588.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
690.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1302.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1467.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
pH |
5.0 |
None |
10.1016/j.bmc.2017.04.014 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
104.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
122.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
123.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
141.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1179670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1374000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1375670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1408000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.7 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.71 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.81 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
7.1 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
55300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
55700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
57300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
60700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5490000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5540000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5810000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5820000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.33 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.4 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
147.6 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
148.63 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
12.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
16.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
19.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
11970.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
13970.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
17530.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
1258.9 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
23109.3 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
IC50 |
390.0 |
nM |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
IC50 |
1600.0 |
nM |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
IC50 relative |
1.607 |
uM |
10.6019/EOS300041 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
IC50 relative |
20.0 |
uM |
10.6019/EOS300044 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
98.98 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
99.94 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
103.13 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.19 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.3 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.69 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
19.31 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.8151 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
16.66 |
% |
10.6019/CHEMBL4513141 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
20000.0 |
nM |
10.6019/CHEMBL4513161 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
121.8 |
nM |
10.1016/j.bmcl.2011.10.028 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
121.8 |
nM |
10.1016/j.ejmech.2017.11.029 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
33.8 |
nM |
None |
| Trypanosoma cruzi Dm28c |
Aminopeptidase |
Inhibition |
7.279 |
% |
10.6019/CHEMBL5305021 |
| None |
ADMET |
CL |
4.4 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
delta logD |
nan |
None |
10.1021/jm0000564 |
| None |
ADMET |
F |
80.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
IC50 |
291000.0 |
nM |
10.1016/j.bmcl.2015.04.095 |
| None |
ADMET |
log10(%HIA +10) |
1.978 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
ADMET |
Log k'o |
1.1 |
None |
10.1021/jm00025a008 |
| None |
ADMET |
MRT |
1.1 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
PPB |
98.4 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
T1/2 |
0.06667 |
hr |
10.1021/jm00084a010 |
| None |
ADMET |
T1/2 |
0.28 |
hr |
10.1021/jm9605593 |
| None |
ADMET |
T1/2 |
1.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
1.1 |
hr |
10.1021/jm00084a010 |
| None |
ADMET |
T1/2 |
6.08 |
hr |
10.1021/jm9605593 |
| None |
ADMET |
T1/2 |
13.0 |
hr |
10.1021/jm00025a008 |
| None |
ADMET |
T1/2 |
40.0 |
hr |
10.1021/jm00084a010 |
| None |
ADMET |
Vdss |
0.28 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Erythrocyte |
HC10 |
20.0 |
uM |
10.6019/CHEMBL4513161 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
1.1 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
4.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.9 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
1.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/jm501543u |
| None |
NON-PROTEIN TARGET |
Fu |
0.021 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
7.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
10.5 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
6710.0 |
nM |
10.1021/jm501543u |
| None |
NON-PROTEIN TARGET |
Inhibition |
nan |
% |
10.1021/jm501543u |
| None |
NON-PROTEIN TARGET |
Potency |
66.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
8912.5 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
10000.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
10583.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
11220.2 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
12589.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
14950.2 |
nM |
None |
| None |
No relevant target |
LogD |
1.73 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogD7.4 |
2.7 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
LogP |
1.47 |
None |
10.1021/ml300216t |
| None |
No relevant target |
pKa |
4.0 |
None |
10.1016/j.bmc.2006.07.068 |
| None |
No relevant target |
pKa |
4.01 |
None |
10.1021/jm00084a010 |
| None |
No relevant target |
pKa |
8.78 |
None |
10.1021/jm00084a010 |
| None |
No relevant target |
pKa |
11.16 |
None |
10.1124/dmd.112.050278 |
| None |
No relevant target |
pKa |
nan |
None |
10.1021/jm0000564 |
| None |
No relevant target |
pKabz |
8.7 |
None |
10.1021/jm00025a008 |
| None |
No relevant target |
pKapy |
3.9 |
None |
10.1021/jm00025a008 |
| None |
Unchecked |
Ac50 |
0.3162 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.7943 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.259 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.585 |
uM |
None |
| None |
Unchecked |
Ac50 |
2.818 |
uM |
None |
| None |
Unchecked |
AC50 |
316.2 |
nM |
None |
| None |
Unchecked |
AC50 |
794.3 |
nM |
None |
| None |
Unchecked |
AC50 |
1260.0 |
nM |
None |
| None |
Unchecked |
AC50 |
1584.9 |
nM |
None |
| None |
Unchecked |
AC50 |
2818.4 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00642 |
| None |
Unchecked |
Control |
29.0 |
% |
10.1021/jm00025a008 |
| None |
Unchecked |
Control |
103.0 |
% |
10.1021/jm00025a008 |
| None |
Unchecked |
Control |
105.0 |
% |
10.1021/jm00025a008 |
| None |
Unchecked |
Hepatotoxicity (acute) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
100000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2017.04.014 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.2c00642 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Inhibition |
nan |
% |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
2059.6 |
nM |
None |
| None |
Unchecked |
Potency |
2310.0 |
nM |
None |
| None |
Unchecked |
Potency |
3162.3 |
nM |
None |
| None |
Unchecked |
Potency |
3548.1 |
nM |
None |
| None |
Unchecked |
Potency |
3981.1 |
nM |
None |
| None |
Unchecked |
Potency |
4466.8 |
nM |
None |
| None |
Unchecked |
Potency |
6309.6 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Potency |
17782.8 |
nM |
None |
| None |
Unchecked |
Potency |
23109.3 |
nM |
None |
| None |
Unchecked |
Potency |
29092.9 |
nM |
None |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |